Health Group Challenges Gilead Patents In The US On Grounds Of Lack Of Novelty 25/10/2017 by Intellectual Property Watch 11 Comments A health advocacy group today announced that it has challenged a set of United States patents for a hepatitis C medicine. The group says drug maker Gilead Sciences has obtained unmerited patents for sofosbuvir, blocking millions of US patients from affordable treatment.
WHO Draft 5-Year Plan Would Focus On Impact & Innovation, Be Discreet On Medicines Access 25/10/2017 by Catherine Saez, Intellectual Property Watch 1 Comment After the new head of the World Health Organization provided his vision for his tenure of the global health institution this summer, the organisation is working on its next programme of work for the period 2019-2023. A preliminary concept note has been issued for public consideration. The note lays out priorities and new orientations and describes a financially sober, more efficient organisation, focused on measurable impact, set on aligning with the United Nations Sustainable Development Goals, and affirming its role as a multi-stakeholder platform of global governance on health, but stays clear of controversial issues, such as the affordability of medicines.
No Progress On WTO Appellate Body Appointments As Ranks Thinning 25/10/2017 by Intellectual Property Watch 2 Comments The imbroglio which might cause a major impediment to the World Trade Organization’s functioning is thickening as the United States continues to block the selection process to fill vacancies in the WTO Appellate Body, according to sources.
Consultation On Future Of WHO Pandemic Flu Programme To Look At Seasonal Viruses, Genetic Information 24/10/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment The World Health Organization mechanism to prepare the world for the next influenza pandemic is pondering its future and possible improvements. Among them are its extension to seasonal influenza, and the inclusion of genetic virus information along with biological samples to keep pace with technological developments. Member states and stakeholders (except the media) have been invited by the WHO to a consultation next month to discuss an analysis showing the potential beneficial or deleterious effects of the suggested changes to the system.
TRIPS Council Serves As Ground For Discussion Of Compulsory Licensing 23/10/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment The escalating prices of medicines has become a growing global concern. Among many issues, intellectual property has been pointed to as providing monopolies that allow for unaffordable prices, in particular in developing countries. Though there is consensus among countries that IP is but one of the issues, the extent of the IP influence is not agreed. The use of compulsory licences as a way for developing countries to grant access to medicines to their populations was discussed during the World Trade Organization committee on intellectual property last week, with divergent opinions.
TRIPS Council: Fears That Non-Violation Complaints Could Undercut Flexibilities In IP Trade Rules 20/10/2017 by Catherine Saez, Intellectual Property Watch 2 Comments World Trade Organization committee members this week were asked to recommend to the upcoming ministerial conference whether to lift or indefinitely prolong a moratorium shielding intellectual property from complaints between members not involving a breach of a WTO agreement. Short of a consensus, the intellectual property committee will have to reconvene next month to try to find agreement. Separately, a two-year extension was granted to countries not yet having ratified the public health amendment to WTO IP rules.
On Eve Of TRIPS Council, Experts Promote Benefits Of IP For Small Enterprises 19/10/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment The importance of intellectual property protection for micro, small and medium-sized enterprises and the challenges they might encounter to ensure that protection was the focus of an event organised this week by a group of developed and middle-income countries at the World Trade Organization. According to the group, the event aimed at drawing connections between IP policies that are under discussion in the WTO IP committee.
“WTO Must Not Be The Odd One Out” – Members Revive Talks On GIs, Genetic Resources 19/10/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment Members of a 2008 World Trade Organization coalition are trying to rekindle a negotiation to provide the same level of protection granted to wines and spirits to other geographical indications, and to grant intellectual property protection to genetic resources and traditional knowledge. The discussion might not make it to the December WTO ministerial, but the group hopes to open a “fresh window” for discussion.
WIPO General Assembly Wrap: Many Decisions Made, But External Offices, Design Treaty Left Hanging 13/10/2017 by Catherine Saez, Intellectual Property Watch 1 Comment After an intense 10 days of negotiations, World Intellectual Property Organization delegates this week managed to close all items of the organisation’s annual General Assemblies, with major decisions taken, such as the approval of the 2018/2019 budget, and a new mandate and work programme for the committee on the protection of genetic resources and traditional knowledge. However the inability to decide at the ambassador level which countries would host new WIPO field offices, and on the convening of a high-level negotiation to conclude a treaty on industrial designs, led to some teeth grinding.
Cancer Group Recommendations To Ensure Medicines Access In South Africa Draft IP Policy 13/10/2017 by Intellectual Property Watch 1 Comment A US cancer group has provided a series of recommendations to the South African government on ways to improve the country’s draft national intellectual property policy, including greater transparency, voluntary licensing, and the use of compulsory licences.